SP

Shree Pushkar Chemicals & Fertilizers Ltd

Q3 FY26Chemicals & Petrochemicals

Shree Pushkar Chemicals & Fertilizers Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price401
Market cap₹1.2K Cr
P/E17.2
Updated23 Aug 2026
Read4 min read

The short version

The company aims to achieve around Rs. FY26 revenue guidance is around Rs.

From Shree Pushkar Chemicals & Fertilizers Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company aims to achieve around Rs. 1,500 crores in revenue in the next financial year (FY27), supported by ramping up two major units (NPKs/phosphoric acid/sulphuric acid and dyes plant) awaiting electricity supply.
  • Plans to increase revenue to Rs. 2,500-3,000 crores by 2029-2030 through ongoing expansions and better capacity utilization.
  • Capacity utilization currently at ~65% in chemicals and ~55% in fertilizers, with expansions involving different products to enhance market penetration and scalability.
  • Expansion projects under Unit 6 (Rs. 110 crores capex) nearing completion by March 2026; Unit 8 (greenfield project with three plants) expected by March 2028.
  • The company projects PAT margins improving to 9-11% by 2029 with revenue growth.
  • Conservative assumption for new units’ utilization is around 60%.
  • They expect further volume growth driven by expanded product offerings in both fertilizers and chemicals markets.

Profitability & Margins

See what Shree Pushkar Chemicals & Fertilizers Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Ongoing Capex of Rs. 155 crores including Unit 6, Dyes Plant in Unit 5, and a 10 MW solar project, expected to complete before March 2026.
  • Unit 6 requires Rs. 25-30 crores more capex; operational trials expected by March 2026 (subject to electricity connection).
  • Greenfield project Unit 8 planned to be completed by March 2028, involving three plants with capacity nearly double that of Unit 6.
  • Rs. 347 crores third expansion announced with promoter preferential allotment.
  • Expansion to include new products different from existing ones for better market penetration.
  • Anticipated revenue growth to Rs. 1,500 crores post-expansions by FY27 and potential to reach Rs. 2,500-3,000 crores by 2029-2030.
  • Awaiting permanent electricity supply; diesel generators deemed impractical for continuous plant operation.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Shree Pushkar Chemicals & Fertilizers Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Shree Pushkar Chemicals & Fertilisers Limited. However, some relevant insights include: - The company is awaiting electricity connection to start production units 5 (Dyes plant) and 6 (NPKs and phosphoric acid), expected to begin trials by March 2026. - Expansion projects totaling Rs. 347 crores are underway, expected to increase revenue to Rs. 1,500 crores by FY27. - Business volumes have been somewhat impacted by seasonal (winter) slowdowns and raw material cost pressures but expected to improve with new capacity utilization. - The company has ongoing export orders, including to Europe and Bangladesh, though Bangladesh volumes temporarily declined due to political uncertainty. - Shree Pushkar is exploring new markets like Egypt, Vietnam, and Indonesia, which could contribute to future order inflows. No specific figures for order book or pending orders are disclosed in the call.

Shree Pushkar Chemicals & Fertilizers Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹13 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Clean Science & Technology Ltd (Q3 FY26)

    Trade deal with Europe starting in FY '27 to potentially reduce tariffs (5.5%-12%), helping competitiveness against China. Key concall takeaways from Clean…

  • Aether Industries Ltd (Q3 FY26)

    The company currently services Baker Hughes with 8 products in commercial production (Site 4) generating a run rate of INR 60 crores this quarter. Key concall…

  • Kesar Petroproducts Ltd (Q3 FY26)

    Export markets constitute about 40% of sales, served through 7-8 distributors across geographies. Key concall takeaways from Kesar Petroprod.'s Q3 FY26…

  • Tata Chemicals Ltd (Q3 FY26)

    Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. Key concall takeaways from Tata…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Shree Pushkar Chemicals & Fertilizers Ltd Q3 FY26 results?

The company aims to achieve around Rs. FY26 revenue guidance is around Rs.

What is Shree Pushkar Chemicals & Fertilizers Ltd share price analysis?

Shree Pushkar Chemicals & Fertilizers Ltd currently shows a neutral. The stock trades at a P/E of 17.2 with a market cap of ₹1,243 Cr. Investors should review the full earnings analysis for detailed insights.

Is Shree Pushkar Chemicals & Fertilizers Ltd planning capital expenditure?

Ongoing Capex of Rs.

Keep Shree Pushkar Chemicals & Fertilizers Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.